{"id":"https://openalex.org/W1972670313","doi":"https://doi.org/10.3109/10826084.2014.980952","title":"Dependence on Prescription Benzodiazepines and Z-drugs Among Young to Middle-aged Patients in France","display_name":"Dependence on Prescription Benzodiazepines and Z-drugs Among Young to Middle-aged Patients in France","alternate_titles":[],"publication_year":2014,"publication_date":"2014-12-04","ids":{"openalex":"https://openalex.org/W1972670313","doi":"https://doi.org/10.3109/10826084.2014.980952","mag":"1972670313","pmid":"https://pubmed.ncbi.nlm.nih.gov/25474727"},"language":"en","primary_location":{"id":"doi:10.3109/10826084.2014.980952","doi":"https://doi.org/10.3109/10826084.2014.980952","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10826084.2014.980952","pdf_url":null,"source":{"id":"https://openalex.org/S131590804","display_name":"Substance Use & Misuse","issn_l":"1082-6084","issn":["1082-6084","1532-2491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Substance Use &amp; Misuse","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1972670313"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006352054","display_name":"Maryl\u00e8ne Guerlais","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Maryl\u00e8ne Guerlais","raw_affiliation_strings":["1CHU de Nantes, Clinical Pharmacology department, Institut de Biologie, 9 quai Moncousu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CHU de Nantes, Clinical Pharmacology department, Institut de Biologie, 9 quai Moncousu, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107329213","display_name":"Marie Grall\u2010Bronnec","orcid":"https://orcid.org/0000-0003-0722-7243","observed_orcids":["https://orcid.org/0000-0003-0722-7243"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]},{"id":"https://openalex.org/I4392021239","display_name":"methodS in Patient-centered outcomes and HEalth ResEarch","ror":"https://ror.org/013m8h627","country_code":"FR","type":"facility","lineage":["https://openalex.org/I110017253","https://openalex.org/I154526488","https://openalex.org/I4392021239","https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie Grall-Bronnec","raw_affiliation_strings":["2CHU Nantes, Addictology department, Nantes, France","MethodS in Patients-centered outcomes and HEalth ResEarch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CHU Nantes, Addictology department, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"MethodS in Patients-centered outcomes and HEalth ResEarch","institution_ids":["https://openalex.org/I4392021239"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108561666","display_name":"Fanny Feuillet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fanny Feuillet","raw_affiliation_strings":["3Plateforme de biom\u00e9trie, Cellule de Promotion de la recherche, CHU, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Plateforme de biom\u00e9trie, Cellule de Promotion de la recherche, CHU, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011236976","display_name":"Marie G\u00e9rardin","orcid":"https://orcid.org/0000-0001-7404-6325","observed_orcids":["https://orcid.org/0000-0001-7404-6325"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marie G\u00e9rardin","raw_affiliation_strings":["1CHU de Nantes, Clinical Pharmacology department, Institut de Biologie, 9 quai Moncousu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1CHU de Nantes, Clinical Pharmacology department, Institut de Biologie, 9 quai Moncousu, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042468344","display_name":"Pascale Jolliet","orcid":"https://orcid.org/0000-0003-0191-9249","observed_orcids":["https://orcid.org/0000-0003-0191-9249"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pascale Jolliet","raw_affiliation_strings":["4CHU Nantes, Clinical Pharmacology department, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4CHU Nantes, Clinical Pharmacology department, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049149134","display_name":"Caroline Victorri\u2010Vigneau","orcid":"https://orcid.org/0000-0002-3745-2532","observed_orcids":["https://orcid.org/0000-0002-3745-2532"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Caroline Victorri-Vigneau","raw_affiliation_strings":["4CHU Nantes, Clinical Pharmacology department, Nantes, France","Service de Pharmacologie Clinique [CHU Nantes]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4CHU Nantes, Clinical Pharmacology department, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]},{"raw_affiliation_string":"Service de Pharmacologie Clinique [CHU Nantes]","institution_ids":["https://openalex.org/I3019204325"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5006352054"],"corresponding_institution_ids":["https://openalex.org/I3019204325"],"apc_list":null,"apc_paid":null,"fwci":2.1828,"has_fulltext":false,"cited_by_count":32,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.85599575,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"50","issue":"3","first_page":"320","last_page":"327"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.46389999985694885,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.46389999985694885,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.30250000953674316,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.15060000121593475,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/benzodiazepine-dependence","display_name":"benzodiazepine dependence","score":0.9800000190734863},{"id":"https://openalex.org/keywords/z-drugs","display_name":"Z-drugs","score":0.9229999780654907},{"id":"https://openalex.org/keywords/non-benzodiazepine-hypnotics","display_name":"non-benzodiazepine hypnotics","score":0.9710000157356262},{"id":"https://openalex.org/keywords/prescription-drug-dependence","display_name":"prescription drug dependence","score":0.5820000171661377},{"id":"https://openalex.org/keywords/young-and-middle-aged-adults","display_name":"young and middle-aged adults","score":0.7639999985694885},{"id":"https://openalex.org/keywords/psychiatric-history","display_name":"psychiatric history","score":0.7369999885559082},{"id":"https://openalex.org/keywords/tolerance-pharmacology-and-immunology","display_name":"tolerance (pharmacology and immunology)","score":0.8379999995231628},{"id":"https://openalex.org/keywords/benzodiazepine-discontinuation","display_name":"benzodiazepine discontinuation","score":0.7559999823570251},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.4320000112056732}],"concepts":[{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6827903985977173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6364294290542603},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.565636396408081},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5154422521591187},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.5057287216186523},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.47685158252716064},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.45860347151756287},{"id":"https://openalex.org/C142052008","wikidata":"https://www.wikidata.org/wiki/Q954027","display_name":"Cross-sectional study","level":2,"score":0.4238811433315277},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.344808965921402},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.321347713470459},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.14850065112113953},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.08248728513717651},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003430","descriptor_name":"Cross-Sectional Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007407","descriptor_name":"Interviews as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010594","descriptor_name":"Pharmacies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016015","descriptor_name":"Logistic Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017831","descriptor_name":"Diagnosis, Dual (Psychiatry)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D055553","descriptor_name":"Prescription Drugs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D063487","descriptor_name":"Prescription Drug Misuse","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.3109/10826084.2014.980952","doi":"https://doi.org/10.3109/10826084.2014.980952","is_oa":false,"landing_page_url":"https://doi.org/10.3109/10826084.2014.980952","pdf_url":null,"source":{"id":"https://openalex.org/S131590804","display_name":"Substance Use & Misuse","issn_l":"1082-6084","issn":["1082-6084","1532-2491"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Substance Use &amp; Misuse","raw_type":"journal-article"},{"id":"pmid:25474727","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25474727","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Substance use & misuse","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-03156111v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-03156111","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Substance Use & Misuse, 2015, 50 (3), pp.320-327. &#x27E8;10.3109/10826084.2014.980952&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W102269956","https://openalex.org/W1591723000","https://openalex.org/W1831669741","https://openalex.org/W1967152496","https://openalex.org/W1968881953","https://openalex.org/W2015725434","https://openalex.org/W2021174696","https://openalex.org/W2024915071","https://openalex.org/W2031337382","https://openalex.org/W2034812410","https://openalex.org/W2040774811","https://openalex.org/W2047445567","https://openalex.org/W2060229259","https://openalex.org/W2070648194","https://openalex.org/W2080492647","https://openalex.org/W2083658315","https://openalex.org/W2094998137","https://openalex.org/W2103482466","https://openalex.org/W2120783400","https://openalex.org/W2122176511","https://openalex.org/W2160311407","https://openalex.org/W2161904103","https://openalex.org/W2163448203","https://openalex.org/W2169064904","https://openalex.org/W2171720080","https://openalex.org/W2433672055","https://openalex.org/W2470286151","https://openalex.org/W3196369884","https://openalex.org/W4298376592"],"related_works":["https://openalex.org/W3081834809","https://openalex.org/W3172835060","https://openalex.org/W2481097774","https://openalex.org/W2899327856","https://openalex.org/W7165379623","https://openalex.org/W2729054905","https://openalex.org/W2383152196","https://openalex.org/W2588465053","https://openalex.org/W3108576783","https://openalex.org/W1993931064"],"abstract_inverted_index":{"BACKGROUND:":[0],"Benzodiazepines":[1],"(BZD)":[2],"and":[3,31,47,115,151,179,186,194],"nonbenzodiazepines":[4],"hypnotics":[5],"(z-drugs)":[6],"are":[7],"recognized":[8],"as":[9],"one":[10,173],"of":[11,23,70,107,131,155,164,177,213,239],"the":[12,18,24,29,74,108,132,153,171,203,208],"most":[13],"widely":[14],"prescribed":[15],"medications":[16],"in":[17,34,77,207,216,237],"world.":[19],"OBJECTIVES:":[20],"The":[21,139],"purpose":[22],"study":[25],"was":[26],"to":[27,36,48,102,124,141,170,226,242],"assess":[28],"BZD":[30],"z-drugs":[32],"dependence":[33,144,165],"young":[35],"middle-aged":[37],"outpatients":[38],"who":[39],"were":[40,61,81,92,95,121],"taking":[41],"BZD/z-drugs":[42,137,143,156],"on":[43],"a":[44,55,64,68,116,187],"chronic":[45],"basis,":[46],"characterize":[49],"their":[50,126],"profile.":[51,127],"METHODS:":[52],"This":[53],"is":[54,145,158],"forward-looking":[56],"cross-sectional":[57],"epidemiological":[58],"study.":[59],"Data":[60],"collected":[62],"through":[63,84],"semi-structured":[65],"interview":[66],"within":[67],"network":[69],"partner":[71],"pharmacies":[72],"from":[73,221],"Nantes":[75],"area,":[76],"France.":[78],"All":[79],"data":[80],"obtained":[82],"exclusively":[83],"patients'":[85],"declarations.":[86],"212":[87],"patients":[88,133],"(19-64":[89],"years":[90],"old)":[91],"included:":[93],"they":[94,99],"considered":[96],"dependent":[97,201],"when":[98],"answered":[100],"positively":[101],"at":[103],"least":[104],"three":[105],"items":[106,176],"DSM":[109],"IV.":[110],"A":[111,160],"multivariate":[112],"logistic":[113],"regression":[114],"principal":[117],"component":[118],"analysis":[119],"(PCA)":[120],"carried":[122],"out":[123],"determine":[125],"RESULTS:":[128],"Almost":[129],"half":[130],"met":[134],"criteria":[135],"for":[136],"dependence.":[138],"risk":[140],"develop":[142],"significantly":[146],"associated":[147],"with":[148,152,175,190],"psychiatric":[149],"history":[150],"quantity":[154],"that":[157],"taken.":[159],"two":[161,204,211,230],"factor":[162],"concept":[163],"could":[166],"be":[167],"identified":[168,206],"according":[169],"PCA:":[172],"axis":[174,189],"\"tolerance\"":[178],"\"long":[180],"term":[181],"administration":[182],"or":[183,219],"higher":[184],"doses\",":[185],"second":[188],"\"concerned":[191],"by":[192],"treatment\"":[193],"\"somatic":[195],"consequences\".":[196],"Conclusions/Importance:":[197],"Among":[198],"this":[199],"BZD/z-drug":[200],"population,":[202],"axes":[205],"PCA":[209],"represent":[210],"profiles":[212,232],"dependence:":[214],"being":[215],"positive":[217],"conditioning":[218],"suffering":[220],"negative":[222],"consequences.":[223],"Clinicians":[224],"need":[225],"know":[227],"them:":[228],"these":[229],"clinical":[231],"may":[233],"have":[234],"an":[235],"influence":[236],"terms":[238],"decision-making,":[240],"especially":[241],"manage":[243],"discontinuation.":[244]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1972670313","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
